H. Lundbeck A/S (HLUYY)

[farviewhill]

I forgot to add in my post yesterday, that in one of heir research partnerships, they are having excellent clinical success in the experimental Alzheimer drug well into phase II. This would be a blockbuster if their clinical success continues.

IMO, it's fun and potentially lucrative to 'play' promising biotech pennys, but here we have a 50+ year old drug company, in partnerships with others all over the world, that have already developed some great drugs and are on the cusp of truly great things with their heart attack and alzheimer research.

All portfolios, imo, should have an exposure to this kind of quality and potential. And by the way, tghey pay a dividend of .35 , as I recall.